PeptideDB

Cyclo(RADfK) 756500-23-9

Cyclo(RADfK) 756500-23-9

CAS No.: 756500-23-9

Cyclo(RADfK) is a selective α(v)β(3) integrin ligand and is extensively utilized in the research related to neovascula
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Cyclo(RADfK) is a selective α(v)β(3) integrin ligand and is extensively utilized in the research related to neovascularization.

Physicochemical Properties


Molecular Formula C28H43N9O7
Molecular Weight 617.697125673294
Exact Mass 617.329
CAS # 756500-23-9
PubChem CID 45107783
Appearance White to off-white solid powder
Density 1.5±0.1 g/cm3
Index of Refraction 1.659
LogP -2.75
Hydrogen Bond Donor Count 9
Hydrogen Bond Acceptor Count 9
Rotatable Bond Count 12
Heavy Atom Count 44
Complexity 1040
Defined Atom Stereocenter Count 5
SMILES

C[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCN=C(N)N)CCCCN)CC2=CC=CC=C2)CC(=O)O

InChi Key SMFHXHGBDFBWOX-BWUHRYBWSA-N
InChi Code

InChI=1S/C28H43N9O7/c1-16-23(40)36-21(15-22(38)39)27(44)37-20(14-17-8-3-2-4-9-17)26(43)35-18(10-5-6-12-29)25(42)34-19(24(41)33-16)11-7-13-32-28(30)31/h2-4,8-9,16,18-21H,5-7,10-15,29H2,1H3,(H,33,41)(H,34,42)(H,35,43)(H,36,40)(H,37,44)(H,38,39)(H4,30,31,32)/t16-,18-,19-,20+,21-/m0/s1
Chemical Name

2-[(2S,5R,8S,11S,14S)-8-(4-aminobutyl)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-14-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Cyclo(RADfK) is a negative control for cyclo(-RGDfK-) (RGD peptide). RGD peptides are modulators of cell adhesion and are recognized by various members of the integrin family [1].
References

[1]. Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics withenhanced tumor-imaging and photosensitizing (PDT) efficacy. Mol Pharm. 2011 Aug 1;8(4):1186-1197.


Solubility Data


Solubility (In Vitro) H2O : ~100 mg/mL (~161.89 mM)
Solubility (In Vivo) Solubility in Formulation 1: 100 mg/mL (161.89 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.6189 mL 8.0945 mL 16.1891 mL
5 mM 0.3238 mL 1.6189 mL 3.2378 mL
10 mM 0.1619 mL 0.8095 mL 1.6189 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.